These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8667650)

  • 1. De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.
    Gahn B; Haase D; Unterhalt M; Drescher M; Schoch C; Fonatsch C; Terstappen LW; Hiddemann W; Büchner T; Bennett JM; Wörmann B
    Leukemia; 1996 Jun; 10(6):946-51. PubMed ID: 8667650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival.
    Goasguen JE; Matsuo T; Cox C; Bennett JM
    Leukemia; 1992 Jun; 6(6):520-5. PubMed ID: 1318461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia.
    Kahl C; Florschütz A; Müller G; Jentsch-Ullrich K; Arland M; Leuner S; Franke A; Höffkes HG
    Ann Hematol; 1997 Sep; 75(3):91-4. PubMed ID: 9368477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.
    Meckenstock G; Aul C; Hildebrandt B; Heyll A; Germing U; Wehmeier A; Giagounidis A; Suedhoff T; Burk M; Soehngen D; Schneider W
    Leuk Lymphoma; 1998 May; 29(5-6):523-31. PubMed ID: 9643566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
    Kuriyama K
    Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.
    Fernandez C; Santos-Silva MC; López A; Matarraz S; Jara-Acevedo M; Ciudad J; Gutierrez ML; Sánchez ML; Salvador-Osuna C; Berruezo MJ; Díaz-Arias JÁ; Palomo-Hernández AM; Colado E; González N; Gallardo D; Asensio A; García-Sánchez R; Saldaña R; Cerveró C; Carboné-Bañeres A; Gutierrez O; Orfao A
    Leukemia; 2013 Nov; 27(11):2149-56. PubMed ID: 23579575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
    Junghanss C; Waak M; Knopp A; Kleine HD; Kundt G; Leithäuser M; Hilgendorf I; Wolff D; Casper J; Freund M
    Neoplasma; 2005; 52(5):402-10. PubMed ID: 16151585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
    Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
    Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
    Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
    Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
    Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
    Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
    Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
    Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
    Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
    Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.
    Perea G; Domingo A; Villamor N; Palacios C; Juncà J; Torres P; Llorente A; Fernández C; Tormo M; Queipo de Llano MP; Bargay J; Gallart M; Florensa L; Vivancos P; Martí JM; Font L; Berlanga J; Esteve J; Bueno J; Ribera JM; Brunet S; Sierra J; Nomdedéu JF;
    Leuk Res; 2005 Oct; 29(10):1109-16. PubMed ID: 16095690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?
    Lemez P; Gáliková J; Haas T
    Neoplasma; 2000; 47(1):41-7. PubMed ID: 10870686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.